Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center

Objectives:This retrospective study aimed to overview the efficacy and side effects of clobazam in patients with drug-resistant epilepsy who were followed in a tertiary epilepsy center.Methods:The patients who had been started clobazam as add-on therapy and have been followed for at least one year w...

Full description

Bibliographic Details
Main Authors: Nermin Görkem ŞİRİN, Betül BAYKAN, Nerses BEBEK
Format: Article
Language:English
Published: Galenos Yayinevi 2020-12-01
Series:Archives of Epilepsy
Subjects:
Online Access: http://archepilepsy.org/archives/archive-detail/article-preview/clobazam-as-an-add-on-therapy-of-patients-with-dru/54683
_version_ 1827888831330779136
author Nermin Görkem ŞİRİN
Betül BAYKAN
Nerses BEBEK
author_facet Nermin Görkem ŞİRİN
Betül BAYKAN
Nerses BEBEK
author_sort Nermin Görkem ŞİRİN
collection DOAJ
description Objectives:This retrospective study aimed to overview the efficacy and side effects of clobazam in patients with drug-resistant epilepsy who were followed in a tertiary epilepsy center.Methods:The patients who had been started clobazam as add-on therapy and have been followed for at least one year were recruited to participate in this study. The clinical, electrophysiologic and imaging features of the patients were reviewed. The side effects and efficacy of clobazam were noted.Results:Twelve patients with drug-resistant epilepsy who had focal epilepsy with structural etiology in nine, focal epilepsy with unknown etiology in one, combined focal and generalized epilepsy in one and epilepsy with myoclonic absences in one were included in this study. All patients had at least two antiepileptic drugs with moderate to high doses before clobazam therapy. The side effects were sedation, irritability and blurred vision in three patients. Two patients became seizure-free and seven patients had improved remarkably (≥50% seizure reduction). Only one patient discontinued the drug because of the side effects.Conclusion:Our results provide evidence in the efficacy of clobazam as add-on therapy in patients with drug-resistant epilepsy.
first_indexed 2024-03-12T20:39:24Z
format Article
id doaj.art-a8332a17d8744b5991cfc5085cfd408b
institution Directory Open Access Journal
issn 2792-0550
language English
last_indexed 2024-03-12T20:39:24Z
publishDate 2020-12-01
publisher Galenos Yayinevi
record_format Article
series Archives of Epilepsy
spelling doaj.art-a8332a17d8744b5991cfc5085cfd408b2023-08-01T11:12:54ZengGalenos YayineviArchives of Epilepsy2792-05502020-12-0126315516010.14744/epilepsi.2020.9124913049054Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy CenterNermin Görkem ŞİRİN0Betül BAYKAN1Nerses BEBEK2 Department of Neurology, Istanbul University İstanbul Faculty of Medicine, İstanbul, Turkey Department of Neurology, Istanbul University İstanbul Faculty of Medicine, İstanbul, Turkey Department of Neurology, Istanbul University İstanbul Faculty of Medicine, İstanbul, Turkey Objectives:This retrospective study aimed to overview the efficacy and side effects of clobazam in patients with drug-resistant epilepsy who were followed in a tertiary epilepsy center.Methods:The patients who had been started clobazam as add-on therapy and have been followed for at least one year were recruited to participate in this study. The clinical, electrophysiologic and imaging features of the patients were reviewed. The side effects and efficacy of clobazam were noted.Results:Twelve patients with drug-resistant epilepsy who had focal epilepsy with structural etiology in nine, focal epilepsy with unknown etiology in one, combined focal and generalized epilepsy in one and epilepsy with myoclonic absences in one were included in this study. All patients had at least two antiepileptic drugs with moderate to high doses before clobazam therapy. The side effects were sedation, irritability and blurred vision in three patients. Two patients became seizure-free and seven patients had improved remarkably (≥50% seizure reduction). Only one patient discontinued the drug because of the side effects.Conclusion:Our results provide evidence in the efficacy of clobazam as add-on therapy in patients with drug-resistant epilepsy. http://archepilepsy.org/archives/archive-detail/article-preview/clobazam-as-an-add-on-therapy-of-patients-with-dru/54683 antiepileptic drugclobazamdrug-resistant epilepsymedically refractory
spellingShingle Nermin Görkem ŞİRİN
Betül BAYKAN
Nerses BEBEK
Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
Archives of Epilepsy
antiepileptic drug
clobazam
drug-resistant epilepsy
medically refractory
title Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
title_full Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
title_fullStr Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
title_full_unstemmed Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
title_short Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
title_sort clobazam as an add on therapy of patients with drug resistant epilepsy experience of a tertiary epilepsy center
topic antiepileptic drug
clobazam
drug-resistant epilepsy
medically refractory
url http://archepilepsy.org/archives/archive-detail/article-preview/clobazam-as-an-add-on-therapy-of-patients-with-dru/54683
work_keys_str_mv AT nermingorkemsirin clobazamasanaddontherapyofpatientswithdrugresistantepilepsyexperienceofatertiaryepilepsycenter
AT betulbaykan clobazamasanaddontherapyofpatientswithdrugresistantepilepsyexperienceofatertiaryepilepsycenter
AT nersesbebek clobazamasanaddontherapyofpatientswithdrugresistantepilepsyexperienceofatertiaryepilepsycenter